Unknown

Dataset Information

0

Fermented Oyster Extract Prevents Ovariectomy-Induced Bone Loss and Suppresses Osteoclastogenesis.


ABSTRACT: There is growing interest in bioactive substances from marine organisms for their potential use against diverse human diseases. Osteoporosis is a skeletal disorder associated with bone loss primarily occurring through enhanced osteoclast differentiation and resorption. Recently, we reported the anti-osteoclastogenic activity of fermented Pacific oyster (Crassostrea gigas) extract (FO) in vitro. The present study focused on investigating the anti-osteoporotic efficacy of FO in bone loss prevention in an experimental animal model of osteoporosis and elucidating the mechanism underlying its effects. Oral administration of FO significantly decreased ovariectomy-induced osteoclast formation and prevented bone loss, with reduced serum levels of bone turnover biomarkers including osteocalcin and C-terminal telopeptide fragment of type I collagen C-terminus (CTX). FO significantly suppressed receptor activator of nuclear factor-?B ligand (RANKL)-induced differentiation of bone marrow-derived macrophages (BMMs) into osteoclasts and attenuated the induction of osteoclast-specific genes required for osteoclastogenesis and bone resorption. Furthermore, FO inhibited RANKL-mediated I?B? and p65 phosphorylation in BMMs. Taken together, these results demonstrate that FO effectively suppresses osteoclastogenesis in vivo and in vitro, and that FO can be considered as a potential therapeutic option for the treatment of osteoporosis and osteoclast-mediated skeletal diseases.

SUBMITTER: Ihn HJ 

PROVIDER: S-EPMC6627411 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications


There is growing interest in bioactive substances from marine organisms for their potential use against diverse human diseases. Osteoporosis is a skeletal disorder associated with bone loss primarily occurring through enhanced osteoclast differentiation and resorption. Recently, we reported the anti-osteoclastogenic activity of fermented Pacific oyster (<i>Crassostrea gigas</i>) extract (FO) in vitro. The present study focused on investigating the anti-osteoporotic efficacy of FO in bone loss pr  ...[more]

Similar Datasets

| S-EPMC4559750 | biostudies-literature
| S-EPMC7011148 | biostudies-literature
| S-EPMC7555585 | biostudies-literature
| S-EPMC7898668 | biostudies-literature
| S-EPMC8596812 | biostudies-literature
| S-EPMC5797611 | biostudies-literature
| S-EPMC6987431 | biostudies-literature
| S-EPMC6307789 | biostudies-literature
| S-EPMC7994615 | biostudies-literature
| S-EPMC5632684 | biostudies-literature